Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

OBJECTIVES: To prospectively investigate in patients with severe COVID-19-associated cytokine storm syndrome (CSS) whether an intensive course of glucocorticoids with or without tocilizumab accelerates clinical improvement, reduces mortality and prevents invasive mechanical ventilation, in compariso...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramiro, Sofia, Mostard, Rémy L M, Magro-Checa, César, van Dongen, Christel M P, Dormans, Tom, Buijs, Jacqueline, Gronenschild, Michiel, de Kruif, Martijn D, van Haren, Eric H J, van Kraaij, Tom, Leers, Mathie P G, Peeters, Ralph, Wong, Dennis R, Landewé, Robert B M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456552/
https://www.ncbi.nlm.nih.gov/pubmed/32719045
http://dx.doi.org/10.1136/annrheumdis-2020-218479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456552/
https://www.ncbi.nlm.nih.gov/pubmed/32719045
http://dx.doi.org/10.1136/annrheumdis-2020-218479

Ejemplares similares